AWS
TXG icon

Atria Wealth Solutions’s 10x Genomics TXG Stock Holding History

Atria Wealth Solutions’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,610
Closed -$101K – 1900
2025
Q1 		$101K Buy
11,610
+822
+8% +$10.4K ﹤0.01% 1793
2024
Q4 		$155K Buy
10,788
+943
+10% +$14.9K ﹤0.01% 1868
2024
Q3 		$222K Buy
+9,845
New +$204K ﹤0.01% 1716

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Atria Wealth Solutions's TXG Position: Q2 2025 in Review

Atria Wealth Solutions sold out of 10x Genomics (TXG) in Q2 2025, closing a stake of 11,610 shares — an estimated $101K sold.

Atria Wealth Solutions first reported a position in TXG in Q3 2024 and held it in 3 quarters. The position peaked at $222K in Q3 2024. 297 funds tracked by Wall St. Rank hold TXG as of Q2 2025.

  • Atria Wealth Solutions reported no remaining 10x Genomics position as of Q2 2025 after selling out during the quarter.
  • Atria Wealth Solutions sold 11,610 10x Genomics shares in Q2 2025, an estimated $101K.
  • Atria Wealth Solutions first reported a position in 10x Genomics in Q3 2024 and held it in 3 quarters.
  • Atria Wealth Solutions's 10x Genomics position peaked at $222K in Q3 2024.
  • 297 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.